Top-News
Pharmazeutika USA

Alnylam Pharmaceuticals News

Aktie
WKN:  A0CBCK ISIN:  US02043Q1076 US-Symbol:  ALNY
151,70 €
+2,85 €
+1,91%
14.06.24 18:21:53
Handeln Depot/Watchlist
Aktienanzahl *
124,53 Mio.
Marktkapitalisierung *
18,55 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
Nasdaq Composite Index
IR-Website
zur Website
*Stand: 31.07.2023
Weiter aufwärts? Long handeln - Jetzt mit Hebel 5,90: ME0WM0

Alnylam Pharmaceuticals News

30.04.24 - PR Newswire
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-​Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional ...
30.04.24 - PR Newswire
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia
Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-​Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional ...
11.03.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY PR Newswire
03.03.24 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY PR Newswire
03.11.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY PR Newswire
25.10.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY PR Newswire
17.10.23 - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNY PR Newswire
27.03.23 - Der Aktionär
Übernahmekandidaten: Große Kauflaune
09.03.23 - PR Newswire
Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics
Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-​Regional Partnership to Commercialize RNAi Therapeutics PR Newswire
09.03.23 - PR Newswire
Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics
Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-​Regional Partnership to Commercialize RNAi Therapeutics PR Newswire
15.09.22 - PR Newswire
Regeneron and Alnylam Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NASH Patients and Healthy Volunteers
Regeneron and Alnylam Report Promising Data from Ongoing Phase 1 Study of ALN-HSD in NASH Patients and Healthy Volunteers PR Newswire
15.08.22 - Der Aktionär
Alnylam: Daten begeistern
03.08.22 - Der Aktionär TV
Opening Bell: Alnylam, Moderna, AMD, PayPal, Match Group, Ferrari
Der Dow Jones ging gestern rund 1,2 Prozent schwächer aus dem Handel. Auch die Technologiewerte verzeichneten Verluste, allerdings deutlich geringere. Der Taiwan-​Konflikt ...
03.08.22 - Der Aktionär
Kursexplosion von 55 Prozent: AKTIONÄR‑Tipp startet nach Studiendaten durch
03.08.22 - PR Newswire
Thinking about trading options or stock in Apple, Alnylam Pharmaceuticals, Atlas Air Worldwide, Alteryx, or Chevron?
Thinking about trading options or stock in Apple, Alnylam Pharmaceuticals, Atlas Air Worldwide, Alteryx, or Chevron? PR Newswire
13.07.22 - Der Aktionär
Alnylam verklagt Pfizer und Moderna erneut – Showdown naht
01.04.22 - Der Aktionär
Schlussglocke: China‑Werte melden sich zurück, GameStop‑News verpufft – der Tag an der Wall Street
01.04.22 - Der Aktionär
Speku­latio­nen um Alnylam – Biotech‑Aktie gibt kräftig Gas
09.12.21 - PR Newswire
Direxion Launches mRNA ETF (MSGR)
Direxion Launches mRNA ETF (MSGR) MSGR Offers Exposure to Rapidly Evolving mRNA Sector PR Newswire
28.09.21 - PR Newswire
ONPATTRO® (patisiran) Now Reimbursed in Canada For the Treatment of Hereditary Transthyretin (TTR)-Mediated Amyloidosis (hATTR)
ONPATTRO® (patisiran) Now Reimbursed in Canada For the Treatment of Hereditary Transthyretin (TTR)-Mediated Amyloidosis (hATTR) Canada NewsWire

Newssuche

Videos

newspaper
13.06.24 -3,86%
Technical Trading: Zukauf-​Chance bei Top-Trade, wenn
Sugar No.11 Long Typ: Turbo Open End WKN: VV50DP Hebel: 5 Laufzeit: OpenEnd Einstieg: prozyklisch ... Mehr »